Barbados vs Costa Rica: Access to anti-retroviral drugs, female
Barbados
67.0%
in 2024
Costa Rica
65.0%
in 2024
Barbados rank
88th
Costa Rica rank
91st
Access to anti-retroviral drugs, female over time
- Barbados
- Costa Rica
How they compare
Barbados currently reports 67.0% against 65.0% in Costa Rica, a difference of 2.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Costa Rica ahead.
Barbados ranks 88th and Costa Rica ranks 91st of 141 countries.
Across the 3 decades both report, Barbados averaged higher in 2 and Costa Rica in 1.
Head to head by decade
| Decade | Barbados | Costa Rica | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.4% | 26.5% | 6.1% | Costa Rica |
| 2010s | 51.6% | 43.0% | 8.6% | Barbados |
| 2020s | 65.8% | 60.2% | 5.6% | Barbados |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Barbados or Costa Rica?
- Barbados, at 67.0% against 65.0% in Costa Rica as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Barbados and Costa Rica?
- 2.0%, with Barbados ahead.
- How many years of comparable data are there for Barbados and Costa Rica?
- 25 years are reported by both, from 2000 to 2024.
- How do Barbados and Costa Rica rank globally for access to anti-retroviral drugs, female?
- Barbados ranks 88th and Costa Rica ranks 91st of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.